Skip to main content
Clinical Trials/CTRI/2022/03/040879
CTRI/2022/03/040879
Not yet recruiting
Phase 3

The Effectiveness of Homoeopathic Medicines in the Management of Benign Pathological Ovarian Masses: An Exploratory Clinical Study

Dr Prem Deeshna Pritam0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: D279- Benign neoplasm of unspecified ovaryHealth Condition 2: N801- Endometriosis of ovary
Sponsor
Dr Prem Deeshna Pritam
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Prem Deeshna Pritam

Eligibility Criteria

Inclusion Criteria

  • 1\)Women between 15\-75 years of age.
  • 2\)Diagnosed as benign pathological ovarian mass on ultrasonography of pelvis.

Exclusion Criteria

  • 1\) Malignant ovarian masses.
  • 2\) Raised CA 125 levels except for endometriotic cysts/ endometriomas
  • 3\) Ovarian masses with complications (intra\-cystic or intra\-abdominal hemorrhage, torsion, infection, rupture)
  • 4\) Pregnant mothers.

Outcomes

Primary Outcomes

Not specified

Similar Trials